{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:48:00Z","timestamp":1790952480263,"version":"4.1.0"},"reference-count":44,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>While substance use contributes to a substantial burden of disease, access to evidence-based harm reduction interventions remains limited or inaccessible. Preliminary research suggests that some individuals use cannabis to reduce the harms associated with their use of other substances, including opioids and stimulants. This study examines factors associated with the self-reported use of cannabis for harm reduction among people who use drugs (PWUD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We drew data from three prospective, community-recruited cohorts of PWUD in Vancouver, Canada, between June 2016 and May 2018. Multivariable generalized linear mixed-effects modeling was used to examine factors associated with the primary outcome of \u201cuse of cannabis for harm reduction,\u201d defined as self-reported use of cannabis to substitute for other substances, treat withdrawal, or come down off other drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>One thousand nine hundred thirty-six participants contributed 5706 observations. In adjusted analyses, daily methamphetamine use (adjusted odds ratio [AOR]=1.43, 95% confidence interval [CI]: 1.09\u20131.89), experiencing barriers to accessing addiction treatment (AOR=1.92, 95% CI: 1.21\u20133.03), and enrollment in addiction treatment modalities other than opioid agonist therapy (AOR=1.64, 95% CI: 1.17\u20132.29) were positively associated with using cannabis for harm reduction. Older age was negatively associated (AOR=0.97, 95% CI: 0.95\u20130.98). Among 1281 (66.2%) participants who use cannabis, daily cannabis use and obtaining cannabis from unregulated dispensaries were also independent correlates of using cannabis for harm reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions:<\/jats:title>\n                    <jats:p>Individuals who were more likely to use cannabis for harm reduction reported difficulty accessing addiction treatment or used substances, such as methamphetamines, where effective treatments are limited. These findings highlight the need to better understand the potential harm-reducing impacts of cannabis among PWUD in these scenarios.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2021.0229","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T10:17:05Z","timestamp":1654078625000},"page":"670-678","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study"],"prefix":"10.1177","volume":"8","author":[{"given":"Janice","family":"Mok","sequence":"first","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-6221","authenticated-orcid":false,"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lake","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"UCLA Cannabis Research Initiative, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-7049","authenticated-orcid":false,"given":"M. Eugenia","family":"Soc\u00edas","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada."},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"e_1_3_5_2_2","unstructured":"United Nations. World Drug Report 2021. United Nations: Vienna 2021."},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62353-7"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0593-y"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0154-1"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0095"},{"key":"e_1_3_5_7_2","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"2016","author":"Nielsen S","year":"2016","unstructured":"Nielsen S, , Larance B, , Degenhardt L, et al. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev. 2016; 2016:CD011117.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30373-X"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.01.002"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111851"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234809"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.12608"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1706626"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/16066359.2012.733465"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0373-7"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.4005"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304059"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0266"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-021-00638-4"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1903434116"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.04.006"},{"key":"e_1_3_5_23_2","first-page":"405","article-title":"Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?","volume":"165","author":"Wood E","year":"2001","unstructured":"Wood E, , Tyndall MW, , Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ. 2001; 165:405\u2013410.","journal-title":"CMAJ"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-3-18"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233463"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200409000-00005"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2011.00342.x"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6817a3"},{"key":"e_1_3_5_29_2","unstructured":"United Nations Office on Drugs and Crime. World Drug Report\u2014Drug Use and Health Consequences. United Nations Office on Drugs and Crime: Vienna 2020."},{"key":"e_1_3_5_30_2","unstructured":"British Columbia Coroners Service. Illicit Drug Toxicity Deaths in BC. British Columbia Coroners Service: Vancouver Canada 2020."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.14755"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020214"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801919494"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236243"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2063-0"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306168"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.08.022"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118799954"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00063"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18101191"},{"key":"e_1_3_5_41_2","first-page":"CD004330","article-title":"Psychosocial treatment for opiate abuse and dependence","volume":"25","author":"Mayet S","year":"2005","unstructured":"Mayet S, , Farrell M, , Ferri M, et al. Psychosocial treatment for opiate abuse and dependence. Cochrane Database Syst Rev. 2005; 25:CD004330;.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_42_2","first-page":"3","article-title":"Analysis of trends in the prevalence of cannabis use and related metrics in Canada","volume":"30","author":"Rotermann M","year":"2019","unstructured":"Rotermann M. Analysis of trends in the prevalence of cannabis use and related metrics in Canada. Health Rep. 2019; 30:3\u201313.","journal-title":"Health Rep"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2015.1058825"},{"key":"e_1_3_5_44_2","unstructured":"Public Health Agency of Canada. Canada's Lower-Risk Cannabis Use Guidelines. Public Health Agency of Canada: Canada 2010."},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00028-3"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2021.0229","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:45Z","timestamp":1777385505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2021.0229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,1]]}},"alternative-id":["10.1089\/can.2021.0229"],"URL":"https:\/\/doi.org\/10.1089\/can.2021.0229","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}